Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 AUD | -0.41% | -0.82% | -16.26% |
03-05 | Australia shares inch lower as miners weigh; GDP data in focus | RE |
02-28 | Australian Clinical Labs Falls 11% After Trimming Interim Dividend on Lower H1 FY24 EPS | MT |
Sales 2024 * | 683M 446M 613M | Sales 2025 * | 711M 464M 638M | Capitalization | 485M 317M 435M |
---|---|---|---|---|---|
Net income 2024 * | 29M 18.93M 26M | Net income 2025 * | 38M 24.81M 34.06M | EV / Sales 2024 * | 0.77 x |
Net Debt 2024 * | 39.25M 25.63M 35.19M | Net Debt 2025 * | 17.81M 11.63M 15.97M | EV / Sales 2025 * | 0.71 x |
P/E ratio 2024 * |
17
x | P/E ratio 2025 * |
12.5
x | Employees | 5,115 |
Yield 2024 * |
3.55% | Yield 2025 * |
4.69% | Free-Float | 55.78% |
Latest transcript on Australian Clinical Labs Limited
1 day | -0.41% | ||
1 week | -0.82% | ||
Current month | -10.04% | ||
1 month | -10.04% | ||
3 months | -20.39% | ||
6 months | -8.68% | ||
Current year | -16.26% |
Managers | Title | Age | Since |
---|---|---|---|
Melinda McGrath
CEO | Chief Executive Officer | - | 14-12-31 |
James Davison
DFI | Director of Finance/CFO | - | 14-12-31 |
Tony Landgren
CTO | Chief Tech/Sci/R&D Officer | - | 08-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Alscher
CHM | Chairman | 56 | 14-12-31 |
Leanne Rowe
BRD | Director/Board Member | 67 | 21-04-27 |
Director/Board Member | - | 23-08-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 2 M€ | -.--% | ||
0.01% | 7 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 2.42 | -0.41% | 296,828 |
24-04-30 | 2.43 | -0.82% | 94,036 |
24-04-29 | 2.45 | -0.41% | 144,588 |
24-04-26 | 2.46 | -1.20% | 246,118 |
24-04-24 | 2.49 | +2.05% | 198,250 |
Delayed Quote Australian S.E., May 01, 2024 at 02:10 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.26% | 316M | |
-28.69% | 85.35B | |
+14.32% | 81.95B | |
+9.37% | 28.99B | |
-11.43% | 16.98B | |
-0.36% | 16.85B | |
-0.24% | 15.35B | |
+4.32% | 12.42B | |
+33.40% | 12.19B | |
-31.40% | 11.89B |
- Stock Market
- Equities
- ACL Stock